SCHEMBL6471776

SCHEMBL6471776

CCCCCOC(=O)c1csc2c1c(=O)n(Cc1ccccc1)c(=O)n2C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.45
MAPK1 P28482 5/20 0.45
CYP3A4 P08684 2/20 0.45
TP53 P04637 2/20 0.45
ALDH1A1 P00352 4/20 0.44
LMNA P02545 3/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
POLB P06746 3/20 0.42
ERCC5 P28715 1/20 0.41
FEN1 P39748 1/20 0.41
MAPT P10636 1/20 0.41
KDM4E B2RXH2 2/20 0.41
HSD17B10 Q99714 1/20 0.41
PKM P14618 2/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6473393 0.97 TSHR (0.47) TSHRMAPK1CYP3A4TP53ALDH1A1
SCHEMBL6470623 0.91 ADORA2B (0.42) TSHRMAPK1LMNANPSR1MEN1
SCHEMBL6474542 0.89 ADORA2B (0.44) TSHRMAPK1CYP3A4TP53ALDH1A1
SCHEMBL7024881 0.89 SCN1A (0.48) TSHRMAPK1TP53ALDH1A1LMNA
SCHEMBL6472052 0.87 MEN1 (0.44) TSHRALDH1A1LMNAMEN1KMT2A
SCHEMBL6471284 0.87 MEN1 (0.46) TSHRCYP3A4ALDH1A1LMNAMEN1
SCHEMBL6472082 0.86 ERCC5 (0.41) TSHRCYP3A4ALDH1A1LMNAMEN1
SCHEMBL6470949 0.86 POLB (0.42) TSHRCYP3A4ALDH1A1LMNAMEN1
SCHEMBL7023571 0.85 ERCC5 (0.41) TSHRCYP3A4ALDH1A1LMNAMEN1
SCHEMBL6465348 0.85 CHRM5 (0.45) MAPK1TP53ALDH1A1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1530475-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 Warner-Lambert Company LLC (US) 2005-05-18 EP disclosed
WO-2004006931-A2 PHARMACEUTICAL COMPOSTIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 WARNER-LAMBERT COMPANY LLC (US) 2004-01-22 WO disclosed
EP-1370562-A1 THIENO[2,3-D]PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS Warner-Lambert Company LLC (US) 2003-12-17 EP disclosed
WO-2002064598-A1 THIENO'2,3-D PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2002-08-22 WO disclosed